Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Scale Biosciences Inc. manages a patent portfolio in the Biotechnology & Pharmaceuticals technology area with 1 pending office action. This single action is under the review of 1 distinct examiner, SALMON, KATHERINE D. The records identify SALMON, KATHERINE D as the busiest examiner.
The prosecution is currently limited to a single distinct art unit. This indicates that the pending matter for Scale Biosciences Inc. is focused within a specific sub-sector of Biotechnology & Pharmaceuticals. SALMON, KATHERINE D is responsible for the busiest examiner pending action, controlling the immediate path to allowance.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SALMON, KATHERINE D | 1 | 42.7% | +38.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18569198 | DEVICE AND METHOD FOR LABELING SAMPLES BY THE SPLIT AND POOL APPROACH | SALMON, KATHERINE D | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18569198 | DEVICE AND METHOD FOR LABELING SAMPLES BY THE SPLIT AND POOL APPROACH | SALMON, KATHERINE D | — |
| Art Unit | Apps |
|---|---|
| 1682 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18569198 | DEVICE AND METHOD FOR LABELING SAMPLES BY THE SPLIT AND POOL APPROACH | SALMON, KATHERINE D | 1682 | §103§112 | Final Rejection | — | Pending | Dec 11, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialScale Biosciences Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Katherine D Salmon has the most, with 1 of Scale Biosciences Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.